Investors

Insider Transactions

Date Name Title Sorted Ascending Type Shares Traded Price Range
Feb 12, 2014 goldstein joseph l Director Sell 1,000 320.62
May 28, 2013 goldstein joseph l Director Sell 4,000 252.20
Nov 6, 2013 goldstein joseph l Director Sell 1,000 300.74
Feb 25, 2014 goldstein joseph l Director Sell 1,000 338.86
Feb 20, 2014 goldstein joseph l Director Sell 1,000 326.96 - 327.17
Mar 25, 2014 goldstein joseph l Director Acquisition (Non Open Market) 10,000 n/a
Aug 6, 2014 goldstein joseph l Director Sell 2,000 331.20
Aug 14, 2014 goldstein joseph l Director Sell 2,000 347.65
Nov 12, 2014 goldstein joseph l Director Sell 5,000 398.31
Nov 12, 2014 goldstein joseph l Director Option Execute 5,000 177.82
Aug 27, 2014 goldstein joseph l Director Sell 2,000 350.31
Feb 20, 2015 goldstein joseph l Director Sell 5,000 423.61 - 424.14
Feb 20, 2015 goldstein joseph l Director Option Execute 5,000 177.82
Nov 25, 2014 poon christine a Director Buy 400 410.00
May 21, 2014 poon christine a Director Buy 255 291.90
May 23, 2013 ryan arthur f Director Disposition (Non Open Market) 3,000 n/a
May 31, 2013 ryan arthur f Director Sell 2,500 249.45 - 249.58
Feb 20, 2015 ryan arthur f Director Sell 29,250 421.72 - 424.58
Feb 20, 2015 ryan arthur f Director Option Execute 29,250 33.42 - 273.67
May 16, 2014 ryan arthur f Director Disposition (Non Open Market) 2,355 n/a
Showing 241-260 of 933 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)